VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $947,418 | +14.5% | 219,310 | +74.7% | 0.01% | +40.0% |
| Q2 2023 | $827,150 | +351.9% | 125,516 | +365.6% | 0.01% | +400.0% |
| Q1 2023 | $183,052 | -92.6% | 26,959 | -91.9% | 0.00% | -92.9% |
| Q4 2022 | $2,465,563 | +43.8% | 333,635 | +92.3% | 0.01% | +40.0% |
| Q3 2022 | $1,714,000 | +104.3% | 173,473 | +125.4% | 0.01% | +100.0% |
| Q2 2022 | $839,000 | -10.6% | 76,954 | -7.2% | 0.01% | -37.5% |
| Q1 2022 | $938,000 | -38.9% | 82,915 | -15.3% | 0.01% | -46.7% |
| Q4 2021 | $1,536,000 | +131.3% | 97,887 | +152.8% | 0.02% | +87.5% |
| Q3 2021 | $664,000 | -32.5% | 38,721 | -15.3% | 0.01% | -27.3% |
| Q2 2021 | $983,000 | -42.8% | 45,702 | -60.1% | 0.01% | -50.0% |
| Q1 2021 | $1,719,000 | +269.7% | 114,444 | +223.6% | 0.02% | +266.7% |
| Q4 2020 | $465,000 | -42.6% | 35,366 | -57.8% | 0.01% | -50.0% |
| Q3 2020 | $810,000 | -31.6% | 83,878 | -19.0% | 0.01% | -40.0% |
| Q2 2020 | $1,185,000 | +431.4% | 103,593 | +382.3% | 0.02% | +233.3% |
| Q1 2020 | $223,000 | -84.3% | 21,481 | -75.2% | 0.01% | -76.9% |
| Q4 2019 | $1,420,000 | +3.2% | 86,552 | -16.4% | 0.03% | -3.7% |
| Q3 2019 | $1,376,000 | +18.0% | 103,579 | +25.1% | 0.03% | +28.6% |
| Q2 2019 | $1,166,000 | -2.8% | 82,764 | +26.9% | 0.02% | -46.2% |
| Q1 2019 | $1,200,000 | +87.8% | 65,199 | +166.6% | 0.04% | +30.0% |
| Q4 2018 | $639,000 | -59.8% | 24,453 | -64.7% | 0.03% | -65.5% |
| Q3 2018 | $1,588,000 | +4311.1% | 69,211 | +2836.4% | 0.09% | +4250.0% |
| Q4 2017 | $36,000 | -92.1% | 2,357 | -90.7% | 0.00% | -92.0% |
| Q3 2017 | $454,000 | +251.9% | 25,387 | +221.3% | 0.02% | +212.5% |
| Q2 2017 | $129,000 | -34.2% | 7,902 | -43.6% | 0.01% | -42.9% |
| Q1 2017 | $196,000 | -3.9% | 13,999 | +9.7% | 0.01% | -12.5% |
| Q4 2016 | $204,000 | -16.7% | 12,764 | -13.2% | 0.02% | 0.0% |
| Q3 2016 | $245,000 | +28.3% | 14,705 | -13.4% | 0.02% | +60.0% |
| Q3 2015 | $191,000 | – | 16,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |